Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Raily Aesthetic Medicine International Holdings Limited has issued a profit warning, expecting a revenue of RMB117 million and a loss of RMB2 million for the first half of 2024, consistent with the previous year’s loss. This continued loss is primarily due to increased investments in research and development and higher share option expenses. The company advises shareholders and potential investors to exercise caution when dealing in its shares.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.